Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medicure (MCUJF) EPS (Basic) (2016 - 2025)

Medicure has reported EPS (Basic) over the past 17 years, most recently at -$0.4 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 1248.56% year-over-year to -$0.4; the TTM value through Dec 2025 reached -$17204.0, up 40.99%, while the annual FY2025 figure was -$0.49, 581.18% down from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.4 at Medicure, down from -$0.02 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $12833.3 in Q2 2023 and troughed at -$40566.7 in Q2 2024.
  • A 5-year average of -$408.43 and a median of $0.0 in 2022 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): soared 301870691.09% in 2023 and later tumbled 1248.56% in 2025.
  • Year by year, EPS (Basic) stood at $0.18 in 2021, then soared by 1934029.62% to $3492.3 in 2022, then crashed by 100.0% to -$0.15 in 2023, then skyrocketed by 79.79% to -$0.03 in 2024, then crashed by 1248.56% to -$0.4 in 2025.
  • Business Quant data shows EPS (Basic) for MCUJF at -$0.4 in Q4 2025, -$0.02 in Q3 2025, and -$8375.0 in Q2 2025.